Related Experiment Video
Updated: Jul 10, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice
Francesco Blasi1, Stefano Aliberti, Luigi Allegra
1Institute of Respiratory Diseases, University of Milan, IRCCS Ospedale Maggiore Fondazione Policlinico-Mangiagalli-Regina Elena, Milano, Italy. francesco.blasi@unimi.it
Background:
It has been reported that Chlamydophila (C.) pneumoniae is involved in the initiation and promotion of asthma and chronic obstructive pulmonary diseases (COPD). Surprisingly, the effect of C. pneumoniae on airway function has never been investigated.
Methods:
In this study, mice were inoculated intranasally with C. pneumoniae (strain AR39) on day 0 and experiments were performed on day 2, 7, 14 and 21.
Results:
We found that from day 7, C. pneumoniae infection causes both a sustained airway hyperresponsiveness and an inflammation. Interferon-gamma (IFN-gamma) and macrophage inflammatory chemokine-2 (MIP-2) levels in bronchoalveolar lavage (BAL)-fluid were increased on all experimental days with exception of day 7 where MIP-2 concentrations dropped to control levels. In contrast, tumor necrosis factor-alpha (TNF-alpha) levels were only increased on day 7. From day 7 to 21 epithelial damage and secretory cell hypertrophy was observed. It is suggested that, the inflammatory cells/mediators, the epithelial damage and secretory cell hypertrophy contribute to initiation of airway hyperresponsiveness.
Conclusion:
Our study demonstrates for the first time that C. pneumoniae infection can modify bronchial responsiveness. This has clinical implications, since additional changes in airway responsiveness and inflammation-status induced by this bacterium may worsen and/or provoke breathlessness in asthma and COPD.
Insights
Chlamydophila pneumoniae infection causes airway hyperresponsiveness and inflammation in mice. This finding suggests the bacterium may worsen respiratory conditions like asthma and COPD.
Area of Science:
- Respiratory medicine
- Infectious diseases
- Immunology
Background:
- Chlamydophila pneumoniae (C. pneumoniae) is implicated in asthma and COPD.
- The impact of C. pneumoniae on airway function remains uninvestigated.
Purpose of the Study:
- To investigate the effect of C. pneumoniae infection on airway function in a mouse model.
Main Methods:
- Mice were intranasally inoculated with C. pneumoniae (strain AR39).
- Airway function, inflammation, and cellular changes were assessed on days 2, 7, 14, and 21 post-infection.
Main Results:
- C. pneumoniae infection led to sustained airway hyperresponsiveness and inflammation starting from day 7.
- Elevated levels of Interferon-gamma (IFN-gamma) and macrophage inflammatory chemokine-2 (MIP-2) were observed.
- Epithelial damage and secretory cell hypertrophy were noted from day 7 to 21.
Conclusions:
- C. pneumoniae infection modifies bronchial responsiveness.
- These modifications, along with inflammation, may exacerbate or trigger breathlessness in asthma and COPD patients.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Atypical Pneumonia
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

